Should testosterone be added to estrogen-progestin therapy for breast protection?

Menopause

Volumn 14, Issue 2, 2007, Pages 159-162

  Burger, Henry G ^a  

^a Jean Hailes Foundation for Women's Health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; METHYLTESTOSTERONE; NORETHISTERONE ACETATE; TESTOSTERONE;

ANDROGEN DEFICIENCY; BREAST CANCER; BREAST CELL; CANCER PREVENTION; CANCER RISK; CELL PROLIFERATION; CLINICAL TRIAL; DRUG DOSAGE FORM COMPARISON; EDITORIAL; ESTROGEN THERAPY; HUMAN; HYPOPITUITARISM; LIBIDO DISORDER; MAMMOGRAPHY; MENOPAUSAL SYNDROME; POSTMENOPAUSE; PROTECTION; RISK REDUCTION;

BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MENOPAUSE; PROGESTINS; TESTOSTERONE;

EID: 34247626413     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/GME.0b013e31802cdddd     Document Type: Editorial

References (33)

1. Bachman G, Bancroft J, Braunstein G, et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification and assessment. Fertil Steril 2002;77:660-665.
2. The North American Menopause Society. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society. Menopause 2005;12:496-511.
3. Lobo R. Androgens in postmenopausal women: production, possible role and replacement options. Obstet Gynecol Surv 2001;56:361-376.
4. Wierman ME, Basson R, Davis R, et al. Androgen therapy in women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2006;91:3697-3710.
5. Alexander J, Dennerstein L, Burger H, Graziottin A. Testosterone and libido in surgically and naturally menopausal women. Womens Health 2006;2:459-477.
6. Burger HG, Hailes J, Menelaus M, et al. The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas 1984;6:351-358.
7. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: a double blind, cross-over study. Psychoneuroendocrinology 1985;10:325-335.
8. Burger HG, Hailes J, Nelson J, Menelaus M. Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women. BMJ 1987;294:936-937.
9. Schifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-688.
10. Goldstat R, Briganti E, Tran J, et al. Transdermal testosterone therapy improves well-being, mood and sexual function in premenopausal women. Menopause 2003;10:390-398.
11. Braunstein GD, Sundwll DA, Katz M, et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebocontrolled trial. Arch Intern Med 2005;165:1582-1589.
12. Buster JE, Kingsberg SA, Aguirre O, Brown C, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005;105:944-952.
13. Davis SR, van der Mooren MJ, van Lunsen RH, et al. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo - controlled trial. Menopause 2006;13:387-396.
14. Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226-5233.
15. Dimitrakakis C. Androgens and mammary growth and neoplasia. Fertil Steril 2002;77(Suppl 4):S26-S33.
16. Somboonporn W, Davis S. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 2004;25:374-388.
17. Labrie F. Dehydroepiandrosterone, androgens and the mammary gland. Gynecol Endocrinol 2006;22:118-130.
18. Zhou J, Ng S, Adesanya-Famuiya O, Anderson K, Bondy C. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 2000;14:1725-1730.
19. Dimitrakakis C, Zhou J, Wang MD, et al. A physiological role for testosterone in limiting estrogenic stimulation of the breast. Menopause 2003;10:292-298.
20. Longcope C. Androgens, estrogens and mammary epithelial proliferation. Menopause 2003;10:274-276.
21. Hofling M, Hirschberg AL, Skoog L, et al. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause 2007;14:183-190.
22. Anderson GL, Chlebowski RT, Rossouw JE, et al. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas 2006;55:103-115.
23. Kuhl H. Is the elevated breast cancer risk observed in the WHI study an artifact? Climacteric 2004;7:319-323.
24. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004;291:1701-1712.
25. Casson PR, Elkind-Hirsch KE, Buster JE, et al. Effect of postmenopausal estrogen replacement on circulating androgens. Obstet Gynecol 1997;90:995-998.
26. Vehkavaara S, Hakala-Ala-Pietila T, Virkamaki A, et al. Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women. Circulation 2000;102:2687-2693.
27. Krug R, Fehm HL, Born J. Selective influence of menstrual cycle on perception of stimuli with reproductive significance. Psychosom Med 1994;56:410-417.
28. Dimitrakakis C, Jones RA, Liu A, Bondy C. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause 2004;11:531-535.
29. Rossouw JE, Anderson GL, Prentice R, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
30. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427.
31. Gelfand MM. It might be wise to consider adding androgen to the estrogen or estrogen-progestin regimens in the appropriate patients. Menopause 2004;11:505-507.
32. Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med 2006;166:1483-1489.
33. Miller KK, Biller BM, Beauregard C, et al. Effects of testosterone replacement in androgen deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2006;91:1683-1690.